Immunocytochemical evidence for a substance related to the bovine pancreatic polypeptide-peptide YY group of peptides in the human fetal gastrointestinal tract.
The time of the first appearance and distribution of substance(s) reacting with the bovine pancreatic polypeptide (BPP) antiserum No. 146-6, i.e., BPP-like immunoreactivity, were studied in the gastrointestinal tract of 5-24-week-old human fetuses using an indirect immunoperoxidase method. The first immunostaining was identified at the 12th week of gestation in the oxyntic and colonic mucosa, and at the 10th week in the ileum. Serial sections alternately labelled with BPP and glicentin (GLI-1) antisera show several patterns. In the enteric and oxyntic mucosa, there is a cell population reacting only with the GLI-1 antiserum intermixed with cells containing both BPP-like and GLI-1-like immunoreactivities. In the oxyntic mucosa, however, certain cells might store BPP-like material only. Specificity tests illustrate cross-reactivity occurring in immunocytochemical studies of extrapancreatic BPP. The ability of synthetic BPP or a chemically related peptide, peptide YY to abolish the BPP antiserum immunoreaction, as well as previous radioimmunoassay data, raise the question of the presence of authentic BPP in GLI-1-containing cells.
D000818:Animals; D000936:Antigen-Antibody Complex; D002417:Cattle; D004064:Digestive System / Q000166:cytology / Q000196:embryology*; D005260:Female; D005333:Fetus; D005753:Gastric Mucosa / Q000166:cytology*; D005865:Gestational Age; D006801:Humans; D007106:Immune Sera; D007124:Immunoenzyme Techniques; D007413:Intestinal Mucosa / Q000166:cytology*; D010179:Pancreas; D010191:Pancreatic Polypeptide / Q000032:analysis*; D019894:Peptide YY; D010455:Peptides / Q000032:analysis*; D011247:Pregnancy
D000936:Antigen-Antibody Complex; D007106:Immune Sera; D010455:Peptides; D019894:Peptide YY; D010191:Pancreatic Polypeptide